Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

John Lamacchia

Orthopaedic Surgery of the Spine Rochester, MI Medical Doctor

NPI 1669465761 CMS profile 120353

1135 W University Dr Ste 450, Ste 450, Rochester, MI 48307

Open in the dashboard

General payments

$178,867

158 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, John Lamacchia of Rochester, MI is reported in the CMS Open Payments database as having received $178,867 across 158 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 82nd percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $43,601 33
2024 General $11,950 24
2023 General $9,081 10
2022 General $7,867 15
2021 General $27,054 14
2020 General $26,702 11
2019 General $52,612 51

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Lamacchia
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to John Lamacchia were reported at $43,601. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year John Lamacchia Orthopaedic Surgery of the Spine median Middle half National median
2019 $52,612 $2,106 $337–$18,608 $163
2020 $26,702 $1,213 $156–$15,082 $114
2021 $27,054 $1,834 $271–$15,617 $132
2022 $7,867 $2,015 $320–$17,036 $149
2023 $9,081 $1,925 $336–$14,599 $160
2024 $11,950 $2,110 $341–$12,483 $164
2025 $43,601 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $82,349 30 payments
  2. Spineology Inc. $30,133 20 payments
  3. RTI Surgical, Inc. $29,085 11 payments
  4. Cerapedics, Inc. $17,469 11 payments
  5. Spinal Elements, Inc. $9,585 20 payments
  6. Kuros Biosciences USA, Inc $7,960 12 payments
  7. Zimmer Biomet Holdings, Inc. $899 3 payments
  8. Medtronic USA, Inc. $420 18 payments
  9. Medtronic, Inc. $415 23 payments
  10. Abbott Laboratories $413 3 payments
  11. Other $138 7 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $148,467 32 payments
  2. Honoraria $11,000 1 payment
  3. Travel and Lodging $10,453 25 payments
  4. Food and Beverage $6,820 98 payments
  5. Compensation for serving as faculty or as a speaker for a medical education program $2,100 1 payment
  6. Entertainment $27 1 payment
Products named General payments · program years 2019–2025
  1. OPTIMESH EXPANDABLE INTERBODY FUSION SYSTEM $30,133 20 payments
  2. NSE - SONOPET $22,250 5 payments
  3. SONOPET IQ $22,075 6 payments
  4. SPETZLER-MALIS $15,500 2 payments
  5. STREAMLINE TL SPINAL FIXATION SYSTEM $15,259 1 payment
  6. FORTILINK-C IBF SYSTEM $12,848 2 payments
  7. i-FACTOR Putty $12,124 8 payments
  8. SILVERGLIDE $10,000 1 payment
  9. MAGNETOS $7,960 12 payments
  10. N/A $6,376 2 payments
  11. Other $37,165 93 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

195

Median for Orthopedic Surgery: 203

Drug cost

$987

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Mupirocin Generic 82 $446
Gabapentin Generic 36 $243
Methocarbamol Generic 27 $146
Tramadol Hcl Generic 39 $128
Amoxicillin Generic 11 $24

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 51 billing codes

Paid by Medicare

$187,316

Medicare's payments for the services billed

Medicare patients

312

Average age 74

Services billed

1,115

192 women, 120 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 38%
Ischemic heart disease 37%
Chronic kidney disease 27%
Depression 27%
Osteoporosis 21%
COPD 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

158 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record